Abstract
Gastroesophageal reflux disease (GERD) is one of the most common gastrointestinal problems worldwide. Proton pump inhibitors (PPIs) are effective in achieving symptom control and preventing complications; however, studies show that approximately 30–40% of patients with GERD fail to respond to aggressive acid-suppressive therapy. While surgical intervention with laparoscopic Nissen fundoplication remains the gold standard, minimally invasive endoscopic antireflux therapies are gaining popularity for the management of PPI-dependent and PPI-refractory GERD. In 2003, we reported that the scarring process post-circumferential mucosal resection around the cardia for Barrett’s esophagus with high-grade dysplasia showed an antireflux effect to PPI-refractory GERD patient (Satodate H, Inoue H, Yoshida T, Usui S, Iwashita M, Fukami N, Shiokawa A, Kudo SE, Gastrointest Endosc 58:288–92, 2003). GER was improved by causing fibrosis at the gastric cardia resulting in the reformation of the cardiac opening. From this experience, we reported antireflux mucosectomy (ARMS) in 2014. The principle of ARMS is that creating a mucosal defect leads to healing by scar formation, which induces narrowing of the gastric cardia opening. We have utilized the cap-assisted endoscopic mucosal resection (EMR-C) technique to perform the mucosectomy. Moreover, antireflux mucosal ablation (ARMA) is a modified antireflux procedure that arises from our experience with ARMS. Mucosal ablation shows scar formation at the gastric cardia similar to the scarring seen with resection and results in narrowing of the cardiac opening. Compared to ARMS, ARMA may be advantageous as it is simpler and can be repeated regardless of the existence of a previous scar. Both ARMS and ARMA may represent effective antireflux procedures with the added advantage of requiring no additional costly devices and leaving no artificial prostheses in situ. In this chapter, we provide an overview of the indications, techniques, and outcomes of ARMS and ARMA.
References
Campos GM, Peters JH, Demeester TR, Oberg S, Crookes PF, Tan S, Demeester SR, Hagen JA, Bremner CG (1999) Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 3:292–300
Dean BB, Gano AD Jr, Knight K, Ofman JJ, Fass R (2004) Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2:656–664
Dent J, Becher A, Sung J, Zou D, Agreus L, Bazzoli F (2012) Systematic review: patterns of reflux-induced symptoms and esophageal endoscopic findings in large-scale surveys. Clin Gastroenterol Hepatol 10:863–873.e3
El-Serag HB, Sweet S, Winchester CC, Dent J (2014) Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 63:871–880
Gyawali CP, Fass R (2018) Management of gastroesophageal reflux disease. Gastroenterology 154:302–318
Inoue H, Ito H, Ikeda H, Sato C, Sato H, Phalanusitthepha C, Hayee B, Eleftheriadis N, Kudo SE (2014) Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study. Ann Gastroenterol 27:346–351
Inoue H, Fujiyoshi Y, Abad MRA, Rodriguez De Santiago E, Sumi K, Iwaya Y, Ikeda H, Onimaru M, Shimamura Y (2019) A novel endoscopic assessment of the gastroesophageal junction for the prediction of gastroesophageal reflux disease: a pilot study. Endosc Int Open 7:E1468–e1473
Khajanchee YS, Hong D, Hansen PD, Swanstrom LL (2004) Outcomes of antireflux surgery in patients with normal preoperative 24-hour pH test results. Am J Surg 187:599–603
Kohn GP, Price RR, Demeester SR, Zehetner J, Muensterer OJ, Awad Z, Mittal SK, Richardson WS, Stefanidis D, Fanelli RD (2013) Guidelines for the management of hiatal hernia. Surg Endosc 27:4409–4428
Roman S, Kahrilas PJ (2014) The diagnosis and management of hiatus hernia. BMJ 349:g6154
Satodate H, Inoue H, Yoshida T, Usui S, Iwashita M, Fukami N, Shiokawa A, Kudo SE (2003) Circumferential EMR of carcinoma arising in Barrett’s esophagus: case report. Gastrointest Endosc 58:288–292
Tack J, Pandolfino JE (2018) Pathophysiology of gastroesophageal reflux disease. Gastroenterology 154:277–288
Vaezi MF, Yang YX, Howden CW (2017) Complications of proton pump inhibitor therapy. Gastroenterology 153:35–48
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this entry
Cite this entry
Tanabe, M., Inoue, H. (2021). Antireflux Mucosectomy and Antireflux Mucosal Ablation: Techniques and Outcomes. In: Testoni, P.A., Inoue, H., Wallace, M.B. (eds) Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy. Springer, Cham. https://doi.org/10.1007/978-3-030-29964-4_40-1
Download citation
DOI: https://doi.org/10.1007/978-3-030-29964-4_40-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-29964-4
Online ISBN: 978-3-030-29964-4
eBook Packages: Springer Reference MedicineReference Module Medicine